During the past decade, Saint Luke's South Hospital conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 103 clinical trials were completed, i.e. on average, 210.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 54 clinical trials were completed. i.e. 675% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's South Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 69 trials, followed by "SWOG Cancer Research Network" with 42 trials sponsored, "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's South Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's South Hospital" are "Breast Cancer" (12 trials), "Colorectal Cancer" (9 trials), "Lung Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Saint Luke's South Hospital" in a lesser frequency.

Most popular intervention types in "Saint Luke's South Hospital" are "Drug" (131 trials), "Other" (107 trials), "Biological" (61 trials), "Procedure" (32 trials) and "Radiation" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Quality-of-Life Assessment" (33 trials), "Paclitaxel" (20 trials), "Carboplatin" (17 trials) and "Bevacizumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's South Hospital" are 132 trials for "All" genders, 35 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Luke's South Hospital". undefined are not yet recruiting, 11 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Saint Luke's South Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's South Hospital, 7 "Phase 1" clinical trials were conducted, 72 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".